[1]向 杰,杨 峰,李 强,等.小柴胡汤加味治疗慢性阻塞性肺疾病急性加重期疗效及对患者细胞免疫状态的影响[J].陕西中医,2023,(5):591-594.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.011]
　XIANG Jie,YANG Feng,LI Qiang,et al.Efficacy of modified Xiaochaihu decoction in the treatment of chronic obstructive pulmonary disease and its influence on cellular immune status[J].,2023,(5):591-594.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.011]
点击复制

小柴胡汤加味治疗慢性阻塞性肺疾病急性加重期疗效及对患者细胞免疫状态的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年5期
页码:
591-594
栏目:
临床研究
出版日期:
2023-05-05

文章信息/Info

Title:
Efficacy of modified Xiaochaihu decoction in the treatment of chronic obstructive pulmonary disease and its influence on cellular immune status
作者:
向 杰; 杨 峰; 李 强; 高 乐
(西安市中医医院,陕西 西安 710021)
Author(s):
XIANG Jie; YANG Feng; LI Qiang; GAO Le
(Xi'an Traditional Chinese Medicine Hospital,Xi'an 710021,China)
关键词:
慢性阻塞性肺疾病急性加重期;  小柴胡汤加味;  肺功能;  NK细胞;  CD4+/CD8+比值;  生活质量
Keywords:
Acute exacerbation of chronic obstructive pulmonary disease;  Modified Xiaochaihu decoction;  Pulmonary function;  NK cell proportion;  CD4+/CD8+ ratio;  Quality of life
分类号:
R 563.9
DOI:
DOI:10.3969/j.issn.1000-7369.2023.05.011
文献标志码:
A
摘要:
目的:探究小柴胡汤加味对于慢性阻塞性肺疾病急性加重期(AECOPD)(少阳合并血瘀证)患者的治疗效果和对患者免疫细胞状态的影响。方法:选取120例AECOPD患者作为观察对象并分为两组(观察组和对照组),分组方法采用区组随机化法,每组60例。对照组采用常规西医方法进行治疗,观察组在其基础上采用小柴胡汤加味治疗,两组患者均治疗10 d。比较治疗后两组患者治疗有效率,对比治疗前和治疗1个月后两组患者中医症候积分、肺功能[用力第一秒呼气量(FEV1)、用力肺活量(FVC)、呼气峰值流速(PEF)]、免疫功能(CD4+、CD8+、NK细胞比例、CD4+/CD8+比值)、生活质量[生活质量测定表(WHOQOL-BREF)]的变化。结果:在治疗1个月后,观察组治疗效果明显优于对照组(P<0.05),两组治疗总有效率比较差异无统计学意义(P>0.05); 两组患者在治疗1个月后中医症候积分、WHOQOL-BREF、FEV1、FVC、PEF水平均明显升高(均P<0.05),且观察组显著高于对照组(均P<0.05); 治疗后两组患者CD4+、NK比例、CD4+/CD8+比值均明显升高,且观察组显著高于对照组(均P<0.05),CD8+比例明显降低,观察组CD8+比例显著低于对照组(均P<0.05)。结论:小柴胡汤加味能显著改善AECOPD患者的肺功能和免疫功能,提高患者生活质量,有利于其预后。
Abstract:
Objective:To explore the therapeutic effect of modified Xiaochaihu decoction on acute exacerbation of chronic obstructive pulmonary disease(AECOPD)(Shaoyang with blood stasis syndrome)in patients and its influence on cellular immune status.Methods:120 patients with AECOPD were divided into observation group(60 cases)and control group(60 cases)by block randomization grouping method.Both groups patients were treated for 10 days.The control group underwent conventional western medicine therapy while the observation group was treated with modified Xiaochaihu decoction on this basis.The effective rate of treatment after treatment,as well as scores of TCM symptoms,pulmonary function indicators [forced expiratory volume in 1 s(FEV1),forced vital capacity(FVC),peak expiratory flow(PEF)],immune function(CD4+,CD8+,NK cell proportion,CD4+/CD8+ ratio)and quality of life [World Health Organization Quality of Life Brief Version(WHOQOL-BREF)] before treatment and after 1 month of treatment were compared between the two groups of patients.Results:After 1 month of treatment,the treatment effect was obviously better in observation group compared to control group(P<0.05),but there was no obvious difference in the effective rate of treatment between the two groups(P>0.05).The scores of TCM symptoms and WHOQOL-BREF,FEV1,FVC and PEF of the two groups of patients were significantly enhanced after 1 month of treatment(all P<0.05),and the above indicators of observation group were significantly higher compared with those of control group(all P<0.05).After treatment,the CD4+,NK proportion and CD4+/CD8+ ratio of the two groups were significantly increased,and the indicators of observation group were significantly higher(all P<0.05),and the proportion of CD8+ was significantly reduced,and the indicator in observation group was significantly lower than that in control group(all P<0.05).Conclusion:Modified xiaochaihu decoction can significantly improve the pulmonary function and immune function and enhance the the quality of life of patients with AECOPD,and it is beneficial to the prognosis.

参考文献/References:

[1] 陈亚红.2022年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J].中国全科医学,2022,25(11):1294-1304,1308.
[2] 迟春花.慢性阻塞性肺疾病急性加重的风险识别和管理新进展[J].中华结核和呼吸杂志,2021,44(1):66-70.
[3] 唐万云,曾玉英,汪秀玲,等.益气活血方治疗慢性阻塞性肺疾病稳定期疗效及对患者肺功能、炎症因子的影响[J].陕西中医,2020,41(11):1576-1579,1583.
[4] 侯 鑫,庞立健,邹吉宇,等.补肺健脾方联合茚达特罗格隆溴铵治疗老年慢性阻塞性肺疾病疗效研究[J].陕西中医,2022,43(12):1694-1697.
[5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会.慢性阻塞性肺疾病诊治指南(2021年修订版)[J].中华结核和呼吸杂志,2021,44(3):170-205.
[6] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志:电子版,2014,6(2):67-80.
[7] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:55-56.
[8] 于琳琳,王 婧,叶智祺,等.五虎汤加味治疗儿童哮喘急性发作期痰热阻肺证的临床随机对照观察[J].中国实验方剂学杂志,2022,28(5):95-101.
[9] 赵 倩,张美玉,季 萍,等.细胞间黏附分子-1在CD4+T细胞辅助B细胞产生抗体中的作用和临床意义[J].上海交通大学学报:医学版,2021,41(5):588-594.
[10] Singh A,Palaniyandi S,Palaniyandi A,et al.Health related quality of life among rural elderly using WHOQOL-BREF in the most backward district of India[J].Journal of Family Medicine and Primary Care,2022,11(3):1162-1168.
[11] 陈云坤,刘 煌,张 凤,等.小柴胡汤合桂枝茯苓丸治疗慢性阻塞性肺疾病急性加重期的临床研究[J].时珍国医国药,2022,33(2):422-424.
[12] 薛公佑,马淑然.试论常见辨证方法所反映与构建的人体系统模型[J].中华中医药杂志,2021,36(5):2456-2460.
[13] 段 珊,彭 旷,王卫忠,等.慢性阻塞性肺疾病急性加重期患者血清补体C5a水平及其与肺功能、IL-6、CRP水平相关性研究[J].陕西医学杂志,2020,49(11):1444-1447.
[14] 卢雯湉,周惠芳.中和思想下张仲景之“和”探赜[J].中华中医药杂志,2022,37(5):2454-2458.
[15] 亓润智,姜菊玲,花宝金.小柴胡汤“和解少阳”临证体悟[J].中华中医药杂志,2019,34(5):2223-2225.
[16] 刘 镭,牛 阳,张思超.从小柴胡汤加减探析丁甘仁经方运用特点[J].中国中医基础医学杂志,2020,26(2):163-165.
[17] 李竹英,孙丽丽,高风丽.从“六经”辨治慢性阻塞性肺疾病体会[J].辽宁中医杂志,2019,46(4):717-719.
[18] 白宇望,杨利生.小柴胡汤加减方治疗上呼吸道感染发热临床研究[J].陕西中医,2019,40(2):223-225,240.
[19] 余 刚,张飔雪.慢性阻塞性肺疾病急性加重期患者血清干扰素-γ、甲壳质酶蛋白-40水平及与预后、肺功能相关性分析[J].陕西医学杂志,2021,50(10):1223-1226.
[20] 王丽敏,张丽艳.解析小柴胡汤“和法”调节自身免疫性疾病机制[J].中华中医药学刊,2018,36(1):218-221.
[21] 盛 雄,邹卓琳.小柴胡汤联合干扰素α治疗慢性乙型肝炎肝纤维化疗效及对细胞免疫状态的影响[J].中华中医药学刊,2018,36(8):2016-2018.
[22] 肖阁敏,郭文海,戴 敏,等.小青龙汤合小柴胡汤治疗肺气虚寒型变应性鼻炎患者疗效与调节Treg细胞相关因子的研究[J].实用医学杂志,2021,37(17):2287-2291.

相似文献/References:

[1]王 伟,足巴措,张 旭.补肺汤治疗慢性阻塞性肺疾病急性加重期疗效及对患者Th1/Th2漂移的影响[J].陕西中医,2023,(8):1078.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.018]
　WANG Wei,ZU Bacuo,ZHANG Xu.Effect of Bufei decoction on acute exacerbation of chronic obstructive pulmonary disease and its influence on Th1/Th2 drift[J].,2023,(5):1078.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.018]

备注/Memo

备注/Memo:
基金项目:陕西省自然科学基础研究计划项目(2014JM2-8202)
更新日期/Last Update: 2023-05-09